Resources / Amneal Selects Direct Customer Solutions as 340B Distributor for Select Products
FOR IMMEDIATE RELEASE
Amneal Selects Direct Customer Solutions as 340B Distributor for
Select Products
Bells, TN – Direct Customer Solutions (DCS), a leading independent third-party logistics provider specializing in pharmaceutical and direct distribution services, announced today that Amneal Pharmaceuticals has selected DCS as their 340B distributor for select products.
Under this partnership, DCS will deliver a controlled distribution
model that supports Amneal’s 340B strategy while ensuring eligible covered
entities access to designated products. The collaboration reflects a shared
commitment to transparency, program integrity, and operational efficiency within
the 340B channel.
DCS will leverage its fully licensed and automated distribution
facility, controlled-temperature warehousing, and nationwide shipping
capabilities to enhance manufacturer oversight and reduce unnecessary
intermediaries.
About Direct Customer Solutions
Founded in 2017 and headquartered in Bells, Tennessee, Direct
Customer Solutions is an independent 3PL operating beyond traditional logistics.
DCS empowers pharmaceutical manufacturers with greater control, transparency,
and optimized operational and financial performance through direct distribution
and 340B solutions.
About Amneal
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), headquartered in
Bridgewater, New Jersey, is a diversified global biopharmaceutical company
focused on expanding access to innovative medicines. The company develops,
manufactures, and distributes a broad portfolio of high- quality generic and
specialty medicines.